about
Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic reviewAdvances in the use of nanocarriers for cancer diagnosis and treatmentGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierUmbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: application for in vivo cell tracking.Stem cells labeled with superparamagnetic iron oxide nanoparticles in a preclinical model of cerebral ischemia: a systematic review with meta-analysis.Intracellular labeling and quantification process by magnetic resonance imaging using iron oxide magnetic nanoparticles in rat C6 glioma cell line.In vivo magnetic resonance imaging tracking of C6 glioma cells labeled with superparamagnetic iron oxide nanoparticles.Tumor growth analysis by magnetic resonance imaging of the C6 glioblastoma model with prospects for the assessment of magnetohyperthermia therapy.The ultrastructural study of tumorigenic cells using nanobiomarkers.In vitro Analysis of Neurospheres Derived from Glioblastoma Primary Culture: A Novel Methodology Paradigm.Study of internalization and viability of multimodal nanoparticles for labeling of human umbilical cord mesenchymal stem cells.An image correction protocol to reduce distortion for 3-T stereotactic MRI.Migraine and motion sickness independently contribute to visual discomfort.Characterization of superparamagnetic iron oxide coated with silicone used as contrast agent for magnetic resonance image for the gastrointestinal tractIn vitro study of CD133 human stem cells labeled with superparamagnetic iron oxide nanoparticlesUltrastructural characterization of CD133+stem cells bound to superparamagnetic nanoparticles: possible biotechnological applicationsCharacterization of Adherent Umbilical Cord Blood Stromal Cells Regarding Passage, Cell Number, and Nano-biomarking UtilizationTriple-modal imaging of stem-cells labeled with multimodal nanoparticles, applied in a stroke modelImage and motor behavior for monitoring tumor growth in C6 glioma model.Multifaceted Mechanisms of Vascular Calcification in Aging.Characterization of the biocompatible magnetic colloid on the basis of Fe3O4 nanoparticles coated with dextran, used as contrast agent in magnetic resonance imagingEvaluation of temperature induction in focal ischemic thermocoagulation modelTherapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo StudyPoly(3-hydroxi-butyrate-co-3-hydroxy-valerate) (PHB-HV) microparticles loaded with holmium acetylacetonate as potential contrast agents for magnetic resonance imagesExpansive Vascular Remodeling and Increased Vascular Calcification Response to Cholecalciferol in a Murine Model of Obesity and Insulin ResistanceNoninvasive Tracking of Hematopoietic Stem Cells in a Bone Marrow Transplant ModelTherapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal modelExcessive cholecalciferol supplementation increases kidney dysfunction associated with intrarenal artery calcification in obese insulin-resistant miceMagnetic hyperthermia therapy in glioblastoma tumor on-a-Chip model
P50
Q27008479-56E8689E-09B5-4557-AFAC-D5A557B73094Q28070065-B5B401CB-9677-4726-8F95-5064D4456D1EQ28071873-BCFDE003-CFE9-496B-948D-137C4B46318DQ37477701-AFB1F10D-8DF9-46E5-9177-08272BCA292BQ38427816-B8CB25C4-524C-43FC-AB9C-022D6D53EE9CQ39262628-DCF3A212-4504-4B7F-8307-8DF041BE67D7Q39262638-D11A613A-3397-46BD-AC9F-54413BB789FDQ39263838-ED4DB861-59A5-4851-A194-52913EEF5801Q39688302-EEA79D8F-3693-4454-8DD3-7AD1C4FBA1B1Q41855021-7160EFFB-B22A-4F9F-A756-470B5A5ACCF1Q48762228-9CA98C39-1FDC-485E-A179-A03DE604A5A7Q48925899-045DF7A4-1393-428A-B092-6125AA26190EQ51823959-2CEDA41C-326A-4C24-A609-85B35DA8FCA2Q57185830-BD999653-F4CA-40B1-BEB5-1E986F486258Q57186325-186F5250-F759-44A5-BA52-D99DCA4F787CQ60198958-7379E78E-A882-4520-810D-0C7007A6071CQ61794479-194FD943-A867-4DE9-8589-62B98193082BQ64103660-CF928344-208A-4C6F-A019-CA066EF875ACQ64891270-028250BC-EA7F-431F-B53B-9F6A753A3740Q64947655-904FFD51-3A1C-4404-A249-FDB4B102D062Q82721408-5EA95502-3497-47AA-BCD5-7B954729D26AQ89430796-43D1C423-BB94-423D-B425-3E23EA9BD913Q89551657-12138E1B-4992-4622-A149-77B59FF39EFDQ90049509-2087CC0F-2B9B-446D-BA50-E0B77F389C37Q90724351-06BAADA8-E188-425F-B5C0-E299CC37CBB3Q91922567-65477877-C039-4D43-B266-2BF68068C802Q92476568-25C1FF18-62BA-458B-9576-1E660D16A8F1Q92528139-C846C969-E048-47DD-BD54-B9BB6BA9148AQ92653728-904C43A4-407D-4A4F-AD2A-FF9D6E251872
P50
description
researcher ORCID ID = 0000-0002-3910-0047
@en
wetenschapper
@nl
name
Lionel Fernel Gamarra
@ast
Lionel Fernel Gamarra
@en
Lionel Fernel Gamarra
@es
Lionel Fernel Gamarra
@nl
type
label
Lionel Fernel Gamarra
@ast
Lionel Fernel Gamarra
@en
Lionel Fernel Gamarra
@es
Lionel Fernel Gamarra
@nl
prefLabel
Lionel Fernel Gamarra
@ast
Lionel Fernel Gamarra
@en
Lionel Fernel Gamarra
@es
Lionel Fernel Gamarra
@nl
P1153
8701181300
P21
P31
P496
0000-0002-3910-0047